BACKGROUND: The risk for subsequent breast cancer in women diagnosed with radial scar lesions (RS) on benign breast biopsy remains controversial. We studied the relative risk of radial scar lesions in a large cohort of patients with benign breast disease (BBD). METHODS: Radial scars were identified in a BBD cohort of 9,262 patients biopsied at Mayo Clinic between 1967 and 1991. Radial scar lesions were classified as proliferative disease without atypia (PDWA) unless atypia was present (classified as atypical hyperplasia [AH]). The observed number of breast cancers developing among those with RS was compared to that expected in the general population using standardized incidence ratios (SIRs, mean follow-up interval 17 years). RESULTS: RS were identified in 439 (4.7%) of the cohort members; 382 (87.0%) contained one RS, 42 (9.6%) contained two, 9 (2.0%) contained three, and 6 (1.4%) contained four or more. The majority of RS (356, 82.4%) were less than 5.0 mm in diameter; 60 (13.9%) were 5.0-9.9 mm, and 16 (3.7%) were 10.0 mm or greater. The relative risk for women with PDWA and RS was 1.88 (95% CI, 1.36-2.53), no different than PDWA without RS [relative risk 1.57 (95% CI, 1.37-1.79) (P=0.29)]. Women with atypical hyperplasia and RS (n=60) had a relative risk of 2.81 (95% CI, 1.29-5.35), while those with atypia but without RS had a relative risk of 3.97 (95% CI, 2.99-5.19). CONCLUSIONS: RS imparts no increased breast cancer risk above that of PDWA or AH without RS.
BACKGROUND: The risk for subsequent breast cancer in women diagnosed with radial scar lesions (RS) on benign breast biopsy remains controversial. We studied the relative risk of radial scar lesions in a large cohort of patients with benign breast disease (BBD). METHODS: Radial scars were identified in a BBD cohort of 9,262 patients biopsied at Mayo Clinic between 1967 and 1991. Radial scar lesions were classified as proliferative disease without atypia (PDWA) unless atypia was present (classified as atypical hyperplasia [AH]). The observed number of breast cancers developing among those with RS was compared to that expected in the general population using standardized incidence ratios (SIRs, mean follow-up interval 17 years). RESULTS:RS were identified in 439 (4.7%) of the cohort members; 382 (87.0%) contained one RS, 42 (9.6%) contained two, 9 (2.0%) contained three, and 6 (1.4%) contained four or more. The majority of RS (356, 82.4%) were less than 5.0 mm in diameter; 60 (13.9%) were 5.0-9.9 mm, and 16 (3.7%) were 10.0 mm or greater. The relative risk for women with PDWA and RS was 1.88 (95% CI, 1.36-2.53), no different than PDWA without RS [relative risk 1.57 (95% CI, 1.37-1.79) (P=0.29)]. Women with atypical hyperplasia and RS (n=60) had a relative risk of 2.81 (95% CI, 1.29-5.35), while those with atypia but without RS had a relative risk of 3.97 (95% CI, 2.99-5.19). CONCLUSIONS:RS imparts no increased breast cancer risk above that of PDWA or AH without RS.
Authors: Cory Morgan; Zeeshan A Shah; Raynal Hamilton; Jean Wang; Joseph Spigel; William Deleon; Patricia Deleon; Tyler Leete; J Mark Fulmer Journal: Proc (Bayl Univ Med Cent) Date: 2012-01
Authors: Patricia A Carney; Andrea J Cook; Diana L Miglioretti; Stephen A Feig; Erin Aiello Bowles; Berta M Geller; Karla Kerlikowske; Mark Kettler; Tracy Onega; Joann G Elmore Journal: J Clin Epidemiol Date: 2011-10-15 Impact factor: 6.437
Authors: Niamh Conlon; Clare D'Arcy; Jennifer B Kaplan; Zenica L Bowser; Anibal Cordero; Edi Brogi; Adriana D Corben Journal: Am J Surg Pathol Date: 2015-06 Impact factor: 6.394
Authors: Geoffrey C Kabat; Joan G Jones; Neal Olson; Abdissa Negassa; Catherine Duggan; Mindy Ginsberg; Rita A Kandel; Andrew G Glass; Thomas E Rohan Journal: Cancer Causes Control Date: 2010-01-19 Impact factor: 2.506
Authors: Sarah A Aroner; Laura C Collins; James L Connolly; Graham A Colditz; Stuart J Schnitt; Bernard A Rosner; Susan E Hankinson; Rulla M Tamimi Journal: Breast Cancer Res Treat Date: 2013-04-23 Impact factor: 4.872
Authors: Carey A Eberle; Salvatore Piscuoglio; Emad A Rakha; Charlotte K Y Ng; Felipe C Geyer; Marcia Edelweiss; Rita A Sakr; Britta Weigelt; Jorge S Reis-Filho; Ian O Ellis Journal: Histopathology Date: 2016-01-07 Impact factor: 5.087
Authors: R J Santen; D C Radisky; A Degnim; M H Frost; C M Vachon; K Ghosh; F Guestini; K M McNamara; H Sasano Journal: Breast Cancer Res Treat Date: 2017-03-23 Impact factor: 4.624